Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-915-5 | CAS number: 111-85-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-chlorooctane
- EC Number:
- 203-915-5
- EC Name:
- 1-chlorooctane
- Cas Number:
- 111-85-3
- Molecular formula:
- C8H17Cl
- IUPAC Name:
- 1-chlorooctane
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix from Aroclor 1254 induced rat liver
- Test concentrations with justification for top dose:
- 1st experiment: 5000, 1667, 556, 185 and 62 µg/plate and 0 µg/plate (control)
2nd experiment: 100, 25, 5, 1, 0.2 µg/plate and 0 µg/plate (control)
3rd experiment: 5, 2.5, 1.25, 0.63 and 0.3 µg/plate and 0 µg/plate (control) - Vehicle / solvent:
- DMSO
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA98
Migrated to IUCLID6: 4 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA100, TA 1535
Migrated to IUCLID6: 2 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- WP2 uvrA
Migrated to IUCLID6: 1 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA1537
Migrated to IUCLID6: 50 µg/plate
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 2 -10 µg/plate 2-Aminoanthracene
- Remarks:
- all tester strains excetp TA98 with metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- TA98 with metabolic activation
Migrated to IUCLID6: 30 µg/plate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 72h
-Titers of overnight cultures: > 10^8
- Selection time (if incubation with a selection agent): 72h
SELECTION AGENT (mutation assays): histidine deficient agar
NUMBER OF REPLICATIONS:triplicates, two assays
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth with strains TA98 and TA100
- Evaluation criteria:
- - negative control in the laboratory historical range for each tester strain
- positive control chemicals produce responses in all tester strains within laboratory historical range
- Mean plate count should be at least two times the concurrent vehicle control group mean in both assays and in a dose dependent response
- selected dose range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extend to 5 mg/plate
- To ensure that appropriate numbers of bacteria are plated, overnight culture titers must be in excess of 10^8 bacteria/ml - Statistics:
- not applicable
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- > 5 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- > 5 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
-
COMPARISON WITH HISTORICAL CONTROL DATA: all control data are in the range of the historical control data
ADDITIONAL INFORMATION ON CYTOTOXICITY: see table below - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
TA1535 | TA1537 | TA98 | TA100 | TA102 | ||||||
Assay 1 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 |
62 | 0.4 | 0.5 | 0.5 | 0.8 | 0.5 | 0.6 | 0.3 | 0.5 | 0.2 | 0.5 |
185 | 0.3 | 0.4 | 0.1 | 0.6 | 0.1 | 0.5 | 0.2 | 0.4 | ||
556 | T | 0.4 | T | T | 0.4 | 0.8 | T | 0.5 | 0.2 | 0.3 |
1667 | T | T | T | T | 0.1 | 0.5 | T | 0.4 | 0 | 0.3 |
5000 | T | T | T | T | T | T | T | T | T | 0.3 |
Assay 2 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 |
0.2 | 0.5 | 1.8 | 1 | 1 | 1.1 | 0.9 | 1.1 | 1.1 | 1 | 0.8 |
1 | 1.2 | 1.1 | 1.3 | 1 | 1.4 | 0.9 | 1.2 | 1.2 | 1 | 1 |
5 | 0.9 | 1 | 1.3 | 1 | 0.6 | 1.2 | 0.9 | 1 | 1 | 0.9 |
25 | 0.3 | 1 | 0.7 | 0.8 | 0.5 | 1 | 0.4 | 0.6 | 0.5 | 0.6 |
100 | 0.4 | 0.4 | 0.3 | 1 | 0.2 | 0.6 | 0.3 | 0.5 | 0.2 | 0.4 |
Assay 3 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 | wo S9 | w S9 |
0.3 | 1.2 | 0.7 | 0.8 | 1.3 | 1.1 | 0.7 | 1.1 | 0.8 | 0.9 | 1.1 |
0.63 | 1.2 | 0.8 | 0.6 | 1.3 | 1.3 | 0.9 | 1 | 1.1 | 0.9 | 1.1 |
1.25 | 0.8 | 0.8 | 0.8 | 1 | 1.1 | 0.9 | 0.9 | 0.9 | 1.2 | 0.9 |
2.5 | 1 | 0.8 | 0.4 | 2 | 0.8 | 1 | 1.1 | 1 | 1 | 1 |
5 | 0.9 | 1 | 0.6 | 2 | 1 | 0.8 | 0.8 | 1 | 0.9 | 1.2 |
wo S9: without metabolic activation
w S9: with metabolic activation
T: Toxicity, no background
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative without metabolic activation
negative with metabolic activation
The test substance induced no mutagenic effect in S. typhimurium and E. coli WP 2 uvrA tester strains used in the test. High cytotoxicity was observed resulting in a reduced background growth in concentration > 5 µg/plate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
